Insulin glargine 300 U/mL beats glargine 100 U/mL in T1DM

(HealthDay)—For patients with type 1 diabetes, the novel, long-acting basal insulin LY2605541 yields greater improvement in glycemic control compared with insulin glargine, according to a study published online Nov. 27 …